Nevro Total Assets 2013-2022 | NVRO

Nevro total assets from 2013 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
Nevro Annual Total Assets
(Millions of US $)
2021 $575
2020 $789
2019 $470
2018 $463
2017 $454
2016 $431
2015 $291
2014 $202
2013 $75
2012 $49
Nevro Quarterly Total Assets
(Millions of US $)
2022-09-30 $606
2022-06-30 $524
2022-03-31 $533
2021-12-31 $575
2021-09-30 $582
2021-06-30 $600
2021-03-31 $776
2020-12-31 $789
2020-09-30 $778
2020-06-30 $753
2020-03-31 $460
2019-12-31 $470
2019-09-30 $448
2019-06-30 $448
2019-03-31 $458
2018-12-31 $463
2018-09-30 $451
2018-06-30 $450
2018-03-31 $445
2017-12-31 $454
2017-09-30 $438
2017-06-30 $421
2017-03-31 $418
2016-12-31 $431
2016-09-30 $420
2016-06-30 $412
2016-03-31 $274
2015-12-31 $291
2015-09-30 $288
2015-06-30 $297
2015-03-31 $192
2014-12-31 $202
2014-09-30 $56
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2012-12-31 $49
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.556B $0.387B
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.645B 22.45
Edwards Lifesciences (EW) United States $46.932B 32.30
Alcon (ALC) Switzerland $33.321B 28.69
STERIS (STE) Ireland $18.019B 22.42
Teleflex (TFX) United States $10.587B 17.18
Fresenius Medical Care AG KGaA (FMS) Germany $8.996B 9.03
Penumbra (PEN) United States $7.452B 1783.82
Globus Medical (GMED) United States $7.103B 36.11
Integer Holdings (ITGR) United States $2.367B 19.00
Glaukos (GKOS) United States $2.263B 0.00
Paragon 28 (FNA) United States $1.534B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.246B 17.74
Artivion (AORT) United States $0.520B 0.00